TSX:WEED (Canopy Growth)
About WEED
Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.
Canopy Growth (TSX: WEED) Latest News
Investing
Saskatchewan Unveils its Plans for Selling Pot in the Province
Investing
Should You Load Up on Canopy Growth Corp. and Aurora Cannabis Inc. on the Recent Dip?
Investing
Buy These 3 Mid Caps for the Price of 1 Cannabis Stock
Dividend Stocks
What Has Everyone So Interested in Artificial Intelligence?
Investing
Could the Cryptocurrency Crowd Be Driving Cannabis Stocks Into Bubble Territory?
Investing
Aphria Inc. Continues to Plunge as Investors Get a Reality Check
Investing
Will Canadian Cannabis Stocks Shrug Off the U.S. Move Against Legal Pot?
Investing
Opinion: Why the Marijuana Sector Is No Better Than Cryptocurrencies
Investing
The Big 4 Canadian Cannabis Producers May Be Ripe for a Very Sharp Pullback
Investing
Canopy Growth Corp.: Is it Just a Bubble or a Real Growth Play?
Investing
Have Marijuana Stocks Grown to Constitute a Significant Proportion of Your Investment Portfolio?